Methocarbamol Tablet, Coated
NDC Package 85477-101-10

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Methocarbamol tablets is methocarbamol is used to treat muscle spasms/pain. This formulation utilizes a tablet, coated delivery system. Marketed by Oncora Pharma, Llc, this product is identified by NDC 85477-101 and is authorized under FDA application ANDA200958.

Identification & Billing

NDC Package Code
85477-101-10
Package Description
100 TABLET, COATED in 1 BOTTLE, PLASTIC
Product Code
85477-101
11-Digit Billing Format
85477010110
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
100 EA
RxNorm Crosswalk
RxCUI: 2611794 - methocarbamol 1000 MG Oral Tablet

Clinical Specifications

Proprietary Name
Methocarbamol
Non-Proprietary Name
Methocarbamol
Substance Name
Methocarbamol
Dosage Form
Tablet, Coated - A solid dosage form that contains medicinal substances with or without suitable diluents and is covered with a designated coating.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
METHOCARBAMOL 1000 mg/1
Pharmacologic Class
Usage Information
Methocarbamol is used to treat muscle spasms/pain. It is usually used along with rest, physical therapy, and other treatment. It works by helping to relax the muscles.

Regulatory & Marketing

Labeler Name
Oncora Pharma, Llc
Product Type
Human Prescription Drug
FDA Application #
ANDA200958
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
11-20-2025
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 85477-101-10 identifies a specific commercial package of 100 tablet, coated in 1 bottle, plastic of Methocarbamol, a human prescription drug labeled by Oncora Pharma, Llc. This tablet, coated is formulated for oral use and contains methocarbamol as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Oncora Pharma, Llc on November 20, 2025. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

Methocarbamol is used to treat muscle spasms/pain. It is usually used along with rest, physical therapy, and other treatment. It works by helping to relax the muscles.

How is this Oncora Pharma, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 85477010110. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
85477-101-10
11-Digit CMS (5-4-2)
85477-0101-10

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.